HLA typing, blood transfusion, and cyclosporine in the North Italy Transplant Program

G. Sirchia; F. Mercuriali; M. Scalamogna

HLA typing, blood transfusion, and cyclosporine in the North Italy Transplant Program

G. Sirchia, F. Mercuriali, M. Scalamogna

IRCCS Multimedica

Research output: Contribution to journal › Article › peer-review

Abstract

CyA had increased graft survival by 25% at one year in the NITP. The new drug, however, has not affected the importance of HLA matching and pretransplant antibodies in conditioning graft outcome. A limited number of pretransplant blood transfusions seems advisable in CyA-treated patients.

Original language	English
Pages (from-to)	86-89
Number of pages	4
Journal	Transplantation Proceedings
Volume	17
Issue number	SUPPL. 2
Publication status	Published - 1985

ASJC Scopus subject areas

Surgery
Transplantation

Cite this

@article{2bdf8e35f45b49e0afd63ad4937ae122,

title = "HLA typing, blood transfusion, and cyclosporine in the North Italy Transplant Program",

abstract = "CyA had increased graft survival by 25% at one year in the NITP. The new drug, however, has not affected the importance of HLA matching and pretransplant antibodies in conditioning graft outcome. A limited number of pretransplant blood transfusions seems advisable in CyA-treated patients.",

author = "G. Sirchia and F. Mercuriali and M. Scalamogna",

year = "1985",

language = "English",

volume = "17",

pages = "86--89",

journal = "Transplantation Proceedings",

issn = "0041-1345",

publisher = "Elsevier USA",

number = "SUPPL. 2",

}

TY - JOUR

T1 - HLA typing, blood transfusion, and cyclosporine in the North Italy Transplant Program

AU - Sirchia, G.

AU - Mercuriali, F.

AU - Scalamogna, M.

PY - 1985

Y1 - 1985

N2 - CyA had increased graft survival by 25% at one year in the NITP. The new drug, however, has not affected the importance of HLA matching and pretransplant antibodies in conditioning graft outcome. A limited number of pretransplant blood transfusions seems advisable in CyA-treated patients.

AB - CyA had increased graft survival by 25% at one year in the NITP. The new drug, however, has not affected the importance of HLA matching and pretransplant antibodies in conditioning graft outcome. A limited number of pretransplant blood transfusions seems advisable in CyA-treated patients.

UR - http://www.scopus.com/inward/record.url?scp=0022376303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022376303&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0022376303

SN - 0041-1345

VL - 17

SP - 86

EP - 89

JO - Transplantation Proceedings

JF - Transplantation Proceedings

IS - SUPPL. 2

ER -

HLA typing, blood transfusion, and cyclosporine in the North Italy Transplant Program

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this